AGC
PEAR

Angelo Gordon & Co’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Angelo Gordon & Co’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,000
Closed -$994K – 271
2021
Q3 		$994K Hold
100,000
– – 0.06% 111
2021
Q2 		$988K Buy
+100,000
New +$988K 0.05% 131